Tokyo, Japan and Cambridge, UK, 14 February 2025 - Nxera Pharma Co., Ltd. ("Nxera” or "the Company”; TSE 4565) provides an ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Astera Labs Inc (NASDAQ:ALAB) shares are trading lower Tuesday on the heels of the company's fourth-quarter financial results ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been ...

As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million ...

Kinross Gold reported increased adjusted net earnings and a record free cash flow in 2024, as the company works toward proceeding with mining at the Redbird open pit at the ...

The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Aker Solutions' revenue rose 43% in the fourth quarter of 2024, and the company expects a solid order backlog in 2025 ...

Nayanthara joins Mahesh Narayanans big-budget film starring Mammootty and Mohanlal, marking her return to Malayalam cinema ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...